Antiamyloid Monoclonal Antibodies in Alzheimer's Disease, Part 1: Patient Selection.
Bateman JR, Carlisle TC, Yang Y, Lachner C, Stockbridge MD, Flashman LA, Chemali Z, Alzbeidi N, Pressman PS, Osibajo AM, Bobrin BD, Martinez-Menendez CJ, Teixeira AL, Daffner KR. Antiamyloid Monoclonal Antibodies in Alzheimer's Disease, Part 1: Patient Selection. J Neuropsychiatry Clin Neurosci. 2025; 37(4):371-377.